Glucose metabolism gene variants modulate the risk of pancreatic cancer

Cancer Prevention Research

Volumn 4, Issue 5, 2011, Pages 758-766

  Dong, Xiaoqun ^a   Li, Yanan ^a   Chang, Ping ^a   Tang, Hongwei ^a   Hess, Kenneth R ^a   Abbruzzese, James L ^a   Li, Donghui ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GLUCOKINASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUTAMINE FRUCTOSE 6 PHOSPHATE TRANSAMINASE 1; HEXOKINASE; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RACE DIFFERENCE; RISK REDUCTION;

AGED; CASE-CONTROL STUDIES; CYTOKINES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUCOKINASE; GLUCOSE; GLUCOSE-6-PHOSPHATE ISOMERASE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HEXOKINASE; HUMANS; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955847328     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0247     Document Type: Article

References (36)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010.CA Cancer J Clin 2010;60:277-300.
2. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306. (Pubitemid 34196324)
3. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007;102:2696-707. (Pubitemid 350179330)
4. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009;301:2553-62.
5. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224-8.
6. Tang H, Dong X, Day RS, Hassan MM, Li D. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis 2010;31:607-13.
7. Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL, Li D. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008;17:3467-73.
8. Garber KEnergy deregulation: licensing tumors to grow. Science 2006;312:1158-9.
9. Thompson CB. Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med 2009;360:813-5.
10. Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006;18:598-608. (Pubitemid 44692479)
11. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
12. Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006;25:4777-86. (Pubitemid 44187625)
13. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208-25. (Pubitemid 46693749)
14. Hammerman PS, Fox CJ, Thompson CB. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci 2004;29:586-92. (Pubitemid 39389078)
15. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 2009;15:740-6.
16. Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008;36:D820-4.
17. Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet 2001;9:969-72. (Pubitemid 34145118)
18. Houwing-Duistermaat JJ, Sandkuijl LA, Bergen AA, van Houwelingen HC. Maximum-likelihood estimation in linkage heterogeneity models including additional information via the EM algorithm. Genet Epidemiol 1995;12:515-27.
19. Strassburger K, Bretz F. Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests. Stat Med 2008;27:4914-27.
20. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol 2009;19:17-24.
21. Arzoine L, Zilberberg N, Ben-Romano R, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity. J Biol Chem 2009;284:3946-55.
22. Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S, et al. Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res 2007;313:3337-48. (Pubitemid 47284060)
23. Dong X, Tang H, Hess KR, Abbruzzese JL, Li D. Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. Cancer 2011;117:480-91.
24. Sethi JK, Vidal-Puig AJ. Wnt signalling at the crossroads of nutritional regulation. Biochem J 2008;416:e11-3.
25. Marshall S. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE 2006;2006: re7.
26. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 2003;28:91-8. (Pubitemid 36165138)
27. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 1990;39:647-52. (Pubitemid 20218960)
28. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-16.
29. Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 2010;53:299-308.
30. Li X, Shu YH, Xiang AH, Trigo E, Kuusisto J, Hartiala J, et al. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes 2009;58:2946-53.
31. Tong X, Zhao F, Thompson CB. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 2009;19:32-7.
32. Araki K, Shimura T, Yajima T, Tsutsumi S, Suzuki H, Okada K, et al. Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8. J Biol Chem 2009;284:32305-11.
33. Tsutsumi S, Yanagawa T, Shimura T, Kuwano H, Raz A. Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res 2004;10:7775-84. (Pubitemid 39557543)
34. Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, Wang J, et al. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer 2002;86:1914-9.
35. Zyromski NJ, Mathur A, Pitt HA, Wade TE, Wang S, Nakshatri P, et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 2009;146:258-63.
36. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.